Celcuity INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Baker Bros. Advisors Lp and 3 others reported changes in beneficial ownership of Celcuity Inc. common stock on July 14, 2026.
NASDAQ
Director Polly A. Murphy transferred 14,048 stock options to a trust for which she and her spouse serve as trustees.
NASDAQ
Director Richard E. Buller reported a transfer of 12,503 stock options to a family trust on June 10, 2026.
NASDAQ
Celcuity Inc. director Polly A. Murphy was granted 1,530 restricted stock units as part of annual compensation.
NASDAQ
Director David Dalvey acquired 1,530 restricted stock units in Celcuity Inc. as part of a standard equity compensation grant.
NASDAQ
Director Charles R. Romp acquired 1,530 restricted stock units in Celcuity Inc. as part of a standard equity compensation grant.
NASDAQ
Director Richard Nigon acquired 1,530 restricted stock units in Celcuity Inc. as part of an equity compensation arrangement.
NASDAQ
Director Leo Furcht acquired 1,530 restricted stock units in Celcuity Inc. as part of a standard equity compensation grant.
NASDAQ
Director Richard E. Buller acquired 1,530 restricted stock units in Celcuity Inc. as part of an equity compensation grant.
NASDAQ
Chief Science Officer Lance G. Laing exercised 1,000 stock options in Celcuity Inc. on June 2, 2026.
NASDAQ
Director Richard E. Buller transferred 1,029 shares of Celcuity Inc. common stock into a family trust.
NASDAQ
Celcuity Inc. Director David Dalvey reported a sale of 25,000 shares of common stock for $140.68 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Celcuity Inc. Director Richard E. Buller reported transactions involving the acquisition of stock options and the sale of common stock, all executed under a pre-established Rule 10b5-1 trading plan.
NASDAQ
Celcuity Inc. director Richard Nigon reported the acquisition of 10,000 shares of common stock on April 9, 2026.
NASDAQ
Director Richard E. Buller exercised 3,000 stock options and sold the resulting shares under a pre-arranged 10b5-1 trading plan.
NASDAQ
Celcuity Inc. Director Charles R. Romp acquired 215 shares of restricted common stock, vesting by April 30, 2026.
NASDAQ
Celcuity Inc. Director David Dalvey reported a future sale of 20,000 shares of common stock at a weighted average price of $120.0269, executed under a pre-arranged 10b5-1 trading plan.
NASDAQ
Celcuity Inc. Director Richard Nigon reported gifting 19,975 shares of common stock on December 15, 2025, reducing his direct beneficial ownership to 89,035 shares, with the Form 4 filing appearing to be delayed.
NASDAQ
Celcuity Inc. Director Richard E. Buller exercised stock options and subsequently sold a portion of the acquired common stock on December 5, 2025, under a pre-arranged plan.
NASDAQ
Celcuity Inc. Director Leo Furcht exercised options to acquire 250 shares of common stock at $7.60 per share, increasing his direct beneficial ownership to 11,000 shares.
NASDAQ
Celcuity Inc. Director Richard E. Buller exercised stock options and subsequently sold a portion of his common stock, while also gifting shares, all through a trust.
NASDAQ
Celcuity Inc. Director David Dalvey sold 15,000 shares of common stock for approximately $1.5 million under a pre-arranged 10b5-1 trading plan.
NASDAQ
Celcuity Inc. Director Richard E. Buller reported exercising stock options and subsequently selling shares, alongside a gift of common stock, all under a Rule 10b5-1 plan.
NASDAQ
Celcuity Inc. Director Richard Nigon acquired 7,917 shares of common stock and exercised warrants, increasing his direct beneficial ownership.
NASDAQ
Baker Bros. Advisors and its principals, Felix and Julian Baker, reported significant purchases of Celcuity Inc. common stock totaling 170,100 shares for approximately $9.6 million.
NASDAQ
Celcuity Inc.'s CEO, Brian F. Sullivan, acquired 104,340 shares of common stock through warrant exercise at $8.05 per share.
NASDAQ
Celcuity Inc.'s Chief Financial Officer, Vicky Hahne, was granted 80,000 stock options with a vesting schedule extending to 2026 and beyond.
NASDAQ
Celcuity Inc.'s Chief Science Officer, Lance G. Laing, was granted 100,000 stock options with an exercise price of $51.57, vesting over time.
NASDAQ
Celcuity Inc.'s CEO, Brian F. Sullivan, was granted 400,000 stock options with an exercise price of $51.57, vesting over time and upon performance milestones.
NASDAQ
Celcuity Inc. Director and 10% owner David Dalvey, through direct holdings and Brightstone Venture Capital Fund, LP, sold 108,325 shares of common stock totaling approximately $4.82 million on July 28, 2025, pursuant to a pre-arranged 10b5-1 trading plan.